Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.57 |
| ▸ | TP53 | P04637 | 4/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 7/20 | 0.55 |
| ▸ | NPC1 | O15118 | 6/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28201245 | 0.79 | CYP1A2 (0.41) | MAPK1LMNACYP1A2HTR2BMEN1 | |
| SCHEMBL19228909 | 0.74 | MEN1 (0.63) | MAPTTP53CYP3A4MAPK1LMNA | |
| Phenindione SCHEMBL29388073 | 0.73 | MAPT (1.00) | MAPTTP53CYP3A4MAPK1LMNA | |
| Phenindione SCHEMBL33831 | 0.73 | MAPT (1.00) | MAPTTP53CYP3A4MAPK1LMNA | |
| SCHEMBL14939521 | 0.73 | RAB9A (0.57) | MAPTTP53CYP3A4MAPK1LMNA | |
| SCHEMBL10557174 | 0.73 | KDM4E (0.57) | MAPTTP53CYP3A4MAPK1LMNA | |
| SCHEMBL17525348 | 0.72 | MAPT (0.71) | MAPTTP53CYP3A4MAPK1LMNA | |
| SCHEMBL28130931 | 0.72 | ALDH1A1 (0.43) | TP53CYP3A4MAPK1HTR2BKDM4E | |
| SCHEMBL30424198 | 0.72 | ACHE (0.46) | LMNAKDM4ESMN1; SMN2L3MBTL1GSTP1 | |
| SCHEMBL19228906 | 0.72 | KMT2A (0.59) | MAPTTP53CYP3A4MAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170269270-A1 | COLORING COMPOSITION, METHOD FOR PRODUCING COLORING COMPOSITION, COLOR FILTER, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-09-21 | — | — | US | disclosed |
| US-20170269270-A1 | COLORING COMPOSITION, METHOD FOR PRODUCING COLORING COMPOSITION, COLOR FILTER, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-09-21 | — | — | US | disclosed |
| WO-2013068785-A1 | INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS | ACTELION PHARMACEUTICALS LTD (CH) | 2013-05-16 | — | — | WO | disclosed |
| US-20090280147-A1 | Compositions comprising dye-loaded particles | NOXELL CORPORATION | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090280147-A1 | Compositions comprising dye-loaded particles | CD68, ASAH2, SORT1 | MAPT 892/4885TP53 254/4885CYP3A4 1794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.